Effect of Yoga & Naturopathy in patients with COVID-19

Phase 3

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/05/025320
• Lead Sponsor: Government Yoga And Naturopathy Medical College Chennai

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

a)Written informed consent prior to performing study procedures. Witnessed oral consent will be accepted in order to avoid paper handling. Written consent by patient or their family members will be obtained wherever applicable.

b)Male or Female adult patient >=18 years and <=75 years of age at the time of recruitment

c)Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR in naso/oropharyngeal swabs or any other relevant specimen

d)Asymptomatic / uncomplicated illness / mild pneumonia COVID-19 as defined by ICMR

Exclusion Criteria

a)Explicit non-willingness to be a part of the research study

b)Patients with moderate/severe stages of COVID19

c)Participation in any other clinical trials

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to progress to next stage of severity i.e., from asymptomatic/uncomplicated/mild pneumonia to moderate/severe stagesTimepoint: At 15 days

Secondary Outcome Measures

Name	Time	Method
Clinical endpoints <br/ ><br>1. Time to All-cause mortality at discharge <br/ ><br>2. All-cause mortality at 28 days <br/ ><br>Measures of morbidity <br/ ><br>1. Number of days lived with infection <br/ ><br>2. Number of days lived with intensive care if the disease has progressed to severe infection from asymptomatic, mild, and moderate stages. <br/ ><br>3. Measuring the symptoms using standard scores <br/ ><br>Patient reported outcome <br/ ><br>1. Quality of life as assessed by WHO-QoL BREF <br/ ><br>2. Anxiety as assessed by GAD scale <br/ ><br>Safety outcomesTimepoint: At Discharge